Eligibility for lipid-lowering drug therapy in primary prevention - How do the Adult Treatment Panel II and Adult Treatment Panel III guidelines compare?
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类]
[关键词] SUBCLINICAL CARDIOVASCULAR-DISEASE;CORONARY-HEART-DISEASE;RISK-FACTORS;MYOCARDIAL-INFARCTION;DIABETES-MELLITUS;PARTICLE-SIZE;OLDER-ADULTS;MEN;ATHEROSCLEROSIS;PRAVASTATIN [时效性]
